γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance

Journal of Immunology

Volumn 193, Issue 4, 2014, Pages 1645-1653

  Kong, Xiaohui ^a   Sun, Rui ^a,b   Chen, Yongyan ^a   Wei, Haiming ^a,b   Tian, Zhigang ^a,b,c  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; CYTOKINE; INTERLEUKIN 17;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; GAMMA DELTA T LYMPHOCYTE; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS CARRIER; VIRUS EXPRESSION; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11B; ARGINASE; CD8-POSITIVE T-LYMPHOCYTES; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE TOLERANCE; INTERLEUKIN-17; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 84905984580     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303432     Document Type: Article

References (38)

1. Gao, B., W. I. Jeong, and Z. Tian. 2008. Liver: An organ with predominant innate immunity. Hepatology 47: 729-736.
2. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13: 29-60.
3. Maini, M. K., C. Boni, C. K. Lee, J. R. Larrubia, S. Reignat, G. S. Ogg, A. S. King, J. Herberg, R. Gilson, A. Alisa, et al. 2000. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191: 1269-1280.
4. Lan, P., C. Zhang, Q. Han, J. Zhang, and Z. Tian. 2013. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance. Hepatology 58: 73-85.
5. Tzeng, H.-T., H.-F. Tsai, H.-J. Liao, Y.-J. Lin, L. Chen, P.-J. Chen, and P.-N. Hsu. 2012. PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model. PLoS ONE 7: e39179.
6. Stross, L., J. Günther, G. Gasteiger, T. Asen, S. Graf, M. Aichler, I. Esposito, D. H. Busch, P. Knolle, T. Sparwasser, and U. Protzer. 2012. Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. Hepatology 56: 873-883.
7. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
8. He, D., H. Li, N. Yusuf, C. A. Elmets, J. Li, J. D. Mountz, and H. Xu. 2010. IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J. Immunol. 184: 2281-2288.
9. Norris, B. A., L. S. Uebelhoer, H. I. Nakaya, A. A. Price, A. Grakoui, and B. Pulendran. 2013. Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity. Immunity 38: 309-321.
10. Tacke, R. S., H. C. Lee, C. Goh, J. Courtney, S. J. Polyak, H. R. Rosen, and Y. S. Hahn. 2012. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 55: 343-353.
11. Hayday, A., and R. Tigelaar. 2003. Immunoregulation in the tissues by gammadelta T cells. Nat. Rev. Immunol. 3: 233-242.
12. Zhao, N., J. Hao, Y. Ni, W. Luo, R. Liang, G. Cao, Y. Zhao, P. Wang, L. Zhao, Z. Tian, et al. 2011. Vg4 gd T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis. J. Immunol. 187: 5007-5014.
13. Mengel, J., F. Cardillo, L. S. Aroeira, O. Williams, M. Russo, and N. M. Vaz. 1995. Anti-g d T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol. Lett. 48: 97-102.
14. Ke, Y., K. Pearce, J. P. Lake, H. K. Ziegler, and J. A. Kapp. 1997. Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J. Immunol. 158: 3610-3618.
15. Hoffmann, J. C., K. Peters, S. Henschke, B. Herrmann, K. Pfister, J.Westermann, and M. Zeitz. 2001. Role of T lymphocytes in rat 2,4,6-trinitrobenzene sulphonic acid (TNBS) induced colitis: increased mortality after gammadelta T cell depletion and no effect of alphabeta T cell depletion. Gut 48: 489-495.
16. Chen, Y., K. Chou, E. Fuchs, W. L. Havran, and R. Boismenu. 2002. Protection of the intestinal mucosa by intraepithelial g d T cells. Proc. Natl. Acad. Sci. USA 99: 14338-14343.
17. Wu, X., J.-Y. Zhang, A. Huang, Y.-Y. Li, S. Zhang, J. Wei, S. Xia, Y. Wan, W. Chen, and Z. Zhang. 2013. Decreased Vd2 gd T cells associated with liver damage by regulation of Th17 response in patients with chronic hepatitis B. J. Infect. Dis. 208: 1294-1304.
18. Chen, M., D. Zhang, W. Zhen, Q. Shi, Y. Liu, N. Ling, M. Peng, K. Tang, P. Hu, H. Hu, and H. Ren. 2008. Characteristics of circulating T cell receptor gammadelta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection. J. Infect. Dis. 198: 1643-1650.
19. Huang, L. R., H. L. Wu, P. J. Chen, and D. S. Chen. 2006. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 103: 17862-17867.
20. Yang, D., L. Liu, D. Zhu, H. Peng, L. Su, Y.-X. Fu, and L. Zhang. 2014. A mouse model for HBV immunotolerance and immunotherapy. Cell. Mol. Immunol. 11: 71-78.
21. Chen, Y., H. Wei, R. Sun, Z. Dong, J. Zhang, and Z. Tian. 2007. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 46: 706-715.
22. Zeng, Z., X. Kong, F. Li, H. Wei, R. Sun, and Z. Tian. 2013. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier. J. Immunol. 191: 4184-4193.
23. Xu, L., W. Yin, R. Sun, H. Wei, and Z. Tian. 2014. Kupffer cell-derived IL-10 plays a key role in maintaining humoral immune tolerance in hepatitis B viruspersistent mice. Hepatology 59: 443-452.
24. Bertoletti, A., and C. Ferrari. 2012. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 61: 1754-1764.
25. Boni, C., P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, et al. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81: 4215-4225.
26. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
27. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
28. Peng, G., H. Y. Wang, W. Peng, Y. Kiniwa, K. H. Seo, and R. F. Wang. 2007. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 27: 334-348.
29. Otsuka, A., S. Hanakawa, Y. Miyachi, and K. Kabashima. 2013. CD39: a new surface marker of mouse regulatory gd T cells. J. Allergy Clin. Immunol. 132: 1448-1451.
30. Sandalova, E., D. Laccabue, C. Boni, T. Watanabe, A. Tan, H. Z. Zong, C. Ferrari, and A. Bertoletti. 2012. Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells. Gastroenterology 143: 78-87.e73.
31. Das, A., M. Hoare, N. Davies, A. R. Lopes, C. Dunn, P. T. Kennedy, G. Alexander, H. Finney, A. Lawson, F. J. Plunkett, et al. 2008. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J. Exp. Med. 205: 2111-2124.
32. Chung, A. S., X. Wu, G. Zhuang, H. Ngu, I. Kasman, J. Zhang, J. M. Vernes, Z. Jiang, Y. G. Meng, F. V. Peale, et al. 2013. An interleukin-17- mediated paracrine network promotes tumor resistance to anti-Angiogenic therapy. Nat. Med. 19: 1114-1123.
33. Wu, P., D. Wu, C. Ni, J. Ye, W. Chen, G. Hu, Z. Wang, C. Wang, Z. Zhang, W. Xia, et al. 2014. gdT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 40: 785-800.
34. Zhang, J. Y., Z. Zhang, F. Lin, Z. S. Zou, R. N. Xu, L. Jin, J. L. Fu, F. Shi, M. Shi, H. F. Wang, and F. S. Wang. 2010. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51: 81-91.
35. Martin, B., K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen. 2009. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
36. Tzeng, H. T., P. N. Hsu, and P. J. Chen. 2013. Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses. J. Gastroenterol. Hepatol. 28(Suppl 1): 116-119.
37. Kennedy, P. T. F., E. Sandalova, J. Jo, U. Gill, I. Ushiro-Lumb, A. T. Tan, S. Naik, G. R. Foster, and A. Bertoletti. 2012. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. Gastroenterology 143: 637-645.
38. Jonas, M. M., J. M. Block, B. A. Haber, S. J. Karpen, W. T. London, K. F. Murray, M. R. Narkewicz, P. Rosenthal, K. B. Schwarz, and B. J. McMahon, Hepatitis B Foundation. 2010. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology 52: 2192-2205.